| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |